Sign in / Join Now
ETFs & Funds
Alex B. Gray
& Daiichi Sankyo Co. expand their research, development and license agreement for the discovery of novel kinase inhibitors.
Add a reply...
Latest StockTalks »
people get ARQL breaking news and analysis by email alert.
Get email alerts on ARQL »
Get latest price
From other sites
ArQule To Report Third Quarter 2016 Financial Results On November 7, 2016
at TheStreet (Mon, 7:00AM)
Can The Uptrend Continue for ArQule (ARQL)?
at Zacks.com (Sep 28, 2016)
ArQule To Present At The Leerink Partners Rare Disease And Immuno-Oncology Roundtable On September 28, 2016
at TheStreet (Sep 21, 2016)
ArQule Announces Publication Of Manuscript Highlighting Preclinical Activity Of FGFR Inhibitor, ARQ 087, In Peer Reviewed Journal
at TheStreet (Sep 15, 2016)
ArQule Reports Second Quarter 2016 Financial Results
at TheStreet (Aug 3, 2016)